• Profile
Close

Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: Impact on diagnostic confidence and diagnostic accuracy

Alzheimer's Research & Therapy Dec 06, 2019

Padovani A, Benussi A, Cotelli MS, et al. - Researchers assessed the clinical value of transcranial magnetic stimulation (TMS) on diagnostic confidence and confidence in mild cognitive impairment (MCI) patients relative to amyloid markers, taking into account the experience of clinicians. Participants in the study included 104 patients with MCI. Overall, TMS had a significant impact on diagnostic reliability and confidence in addition to routine clinical evaluation in patients with MCI, comparable to well-established amyloidosis biomarkers.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay